Timeline

Fernando Batista
Post-doc
09 Sep 2020
publication

Polymorphisms of IL-4 and IL-4R are associated to some demographic characteristics of differentiated thyroid cancer patients but are not determinants of risk in the Brazilian population.

Read more
01 Jun 2020
publication

Unraveling the role of thiosulfate sulfurtransferase in metabolic diseases.

Read more
08 May 2020
publication

Molecular Target Validation of Aspartate Transcarbamoylase from Plasmodium falciparum by Torin 2.

Read more
01 Mar 2020
publication

A novel mechanism of inhibition by phenylthiourea on PvdP, a tyrosinase synthesizing pyoverdine of Pseudomonas aeruginosa.

Read more
01 Feb 2020
publication

New directions in antimalarial target validation.

Read more
11 Mar 2018
publication

Identification of a non-competitive inhibitor of Plasmodium falciparum aspartate transcarbamoylase.

Read more
01 Feb 2018
publication

Serum interleukin measurement may help identify thyroid cancer patients with active disease.

Read more
01 Jan 2018
publication

Oligomeric interfaces as a tool in drug discovery: Specific interference with activity of malate dehydrogenase of Plasmodium falciparum in vitro.

Read more
12 Dec 2017
publication

Tyrosine kinase inhibitor sensitive PDGFRΑ mutations in GIST: Two cases and review of the literature.

Read more
01 Jan 2017
publication

Drug Target Validation Methods in Malaria – Protein Interference Assay (PIA) as a Tool for Highly Specific Drug Target Validation.

Read more
01 Jul 2016
publication

Crystal structure of truncated aspartate transcarbamoylase from Plasmodium falciparum.

Read more
01 Apr 2016
publication

Gene expression of thyroid-specific transcription factors may help diagnose thyroid lesions but are not determinants of tumor progression.

Read more
11 May 2015
team

Structural Microbiology

Read more
01 Oct 2014
publication

Obesity and thyroid cancer.

Read more
01 Jan 2014
publication

CD8+ TIL recruitment may revert the association of MAGE A3 with aggressive features in thyroid tumors.

Read more